Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2
H. Lv, O. T.-Y. Tsang, R. T. Y. So, Y. Wang, H. Liu, G. K. Yip, Q. W. Teo, Y. Lin, W. Liang, J. Wang, W. W. Ng, I. A. Wilson, M. Peiris, N. C. Wu, C. K. P. Mok
The paper examines the serological response to the N-terminal domain (NTD) of SARS-CoV-2, showing it is less cross-reactive with SARS-CoV and less effective as an immunogen compared to the RBD.
bioRxiv · Feb 17, 2021 · PreprintImmunology